Status: Available
Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)
The protocol is designed to provide access to patients to the Clinimacs® CD34 TCRαβ system to prepare cells for an unlabeled indication using an HLA-compatible related or unrelated donor for allogenic transplant.
Trial details
Age: Up to 21Biological sex: AllType: Expanded AccessSponsor: Victor AquinoUpdated: Oct 14, 2025Locations: 1
Eligibility criteria
Age less than 22 years of age [+26]
Pregnant or lactating females are ineligible as the risk to unborn children and... [+2]